Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent Progress in the Development of Selective MAGL Modulators (2020-2026).

Molecules (Basel, Switzerland)·2026
Same author

Insertion of SnCl<sub>2</sub> into the Pd-Cl bond: mechanistic elucidation and antitumor evaluation of trichlorostannyl palladium-NHC allyl complexes in ovarian cancer models.

Dalton transactions (Cambridge, England : 2003)·2026
Same author

Novel Insights on Benzo[<i>b</i>]thiophene Analogues for MAO-B Inhibition and Neuroprotection: Design, Synthesis, Molecular Modelling Studies and Biological Activity.

Antioxidants (Basel, Switzerland)·2026
Same author

Development of Glycoconjugated MAGL Inhibitors with Glucose-Dependent Antiproliferative Activity.

International journal of molecular sciences·2026
Same author

Structure-based design of new pyrazole inhibitors targeting Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH).

European journal of medicinal chemistry·2026
Same author

Recent Advances in Development of Small Molecules to Fight Cancer-Second Edition.

Molecules (Basel, Switzerland)·2026

Related Experiment Video

Updated: Dec 23, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K

Application of MM-PBSA Methods in Virtual Screening.

Giulio Poli1, Carlotta Granchi1, Flavio Rizzolio2,3

  • 1Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.

Molecules (Basel, Switzerland)
|April 29, 2020
PubMed
Summary

This review highlights the Molecular Mechanics-Poisson Boltzman Surface Area (MM-PBSA) method for enhancing virtual screening (VS) in drug discovery. MM-PBSA improves the accuracy of identifying potential drug candidates by providing reliable binding affinity estimations.

Keywords:
MM-PBSAdockingrescoringvirtual screening

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.4K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.1K

Related Experiment Videos

Last Updated: Dec 23, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.4K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.1K

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Pharmacology

Background:

  • Computer-aided drug design (CADD) is integral to modern medicinal chemistry.
  • Receptor-based virtual screening (VS) using molecular docking is a key strategy for identifying novel drug candidates.
  • Improving the accuracy of docking to better distinguish active ligands from inactive compounds remains a critical challenge.

Purpose of the Study:

  • To review the application of the Molecular Mechanics-Poisson Boltzman Surface Area (MM-PBSA) method in virtual screening (VS) studies.
  • To demonstrate how MM-PBSA can enhance the reliability of ligand-protein binding affinity estimations.
  • To provide guidelines for effectively employing MM-PBSA in VS campaigns.

Main Methods:

  • Focus on the Molecular Mechanics-Poisson Boltzman Surface Area (MM-PBSA) method for calculating binding free energies.
  • Application of MM-PBSA for rescoring ligand-protein complexes identified by molecular docking.
  • Review of successful VS campaigns and evaluation studies utilizing MM-PBSA.

Main Results:

  • MM-PBSA offers more reliable estimations of ligand-protein binding affinities compared to standard docking scoring functions.
  • Successful applications of MM-PBSA have been demonstrated in various VS studies.
  • The method aids in improving the hit rates of VS campaigns by enhancing the discrimination of true active ligands.

Conclusions:

  • The MM-PBSA method is a valuable tool for improving the accuracy and efficiency of virtual screening in drug discovery.
  • Its application can significantly boost the success rate of identifying novel hit compounds.
  • This review provides practical insights and guidelines for researchers to effectively implement MM-PBSA in their VS strategies.